Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle announced publication of an intended use survey for DecisionDx®-SCC for patients diagnosed with high-risk cutaneous squamous cell carcinoma.
Castle announced publication of an intended use survey for DecisionDx®-SCC for patients diagnosed with high-risk cutaneous squamous cell carcinoma.
NYC Healthcare Heroes Expands Deliveries to 5,000 Emergency Medical Services and Disaster Services Workers
12:00am, Thursday, 14'th May 2020
NYC Healthcare Heroes is expanding the program to deliver thousands of bags of food and supplies to over 5,000 EMS and disaster services workers.
Castle Biosciences Inc (CSTL) Q1 2020 Earnings Call Transcript
10:01am, Tuesday, 12'th May 2020
CSTL earnings call for the period ending March 31, 2020.
Global Melanoma Markets, Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares (2016-2024) - ResearchAndMarkets.com
12:00am, Tuesday, 12'th May 2020
The
Castle Biosciences Announces First Quarter 2020 Results
08:05pm, Monday, 11'th May 2020
Castle today announced its financial results for the first quarter ended March 31, 2020.
Castle Biosciences Announces First Quarter 2020 Results
12:00am, Monday, 11'th May 2020
Castle today announced its financial results for the first quarter ended March 31, 2020.
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Castle announced the publication of a clinical utility model for its cutaneous squamous cell carcinoma (SCC) prognostic test, DecisionDx®-SCC.
Castle today announced the publication of development and validation data for DecisionDx®-SCC.
Castle Biosciences' Shares March Higher, Can It Continue?
12:53pm, Tuesday, 28'th Apr 2020
As of late, it has definitely been a great time to be an investor in Castle Biosciences.
Castle Biosciences to Release First Quarter 2020 Financial Results and Host Conference Call on Monday, May 11, 2020
11:00am, Monday, 27'th Apr 2020
Castle Biosciences announced that it will release its financial results for the first quarter 2020, after the close of market on Monday, May 11, 2020.
Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
12:35pm, Saturday, 11'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Castle Biosciences to Present at the 19th Annual Needham Virtual Healthcare Conference
11:00am, Monday, 06'th Apr 2020
Castle is scheduled to present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020, at 3:30 p.m. Eastern.
Castle Biosciences Appoints Miles Harrison to Board of Directors
11:00am, Thursday, 02'nd Apr 2020
Castle today announced that Miles Harrison has been appointed to the board of directors, effective immediately.
